393 related articles for article (PubMed ID: 15661808)
1. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
Yuan H; Gong A; Young CY
Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
[TBL] [Abstract][Full Text] [Related]
2. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
Ren F; Zhang S; Mitchell SH; Butler R; Young CY
Oncogene; 2000 Apr; 19(15):1924-32. PubMed ID: 10773882
[TBL] [Abstract][Full Text] [Related]
3. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
4. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.
Mu X; Chang C
Prostate; 2003 Oct; 57(2):129-33. PubMed ID: 12949936
[TBL] [Abstract][Full Text] [Related]
5. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.
Yuan H; Young CY; Tian Y; Liu Z; Zhang M; Lou H
Mol Cell Biochem; 2010 Jun; 339(1-2):253-62. PubMed ID: 20148354
[TBL] [Abstract][Full Text] [Related]
7. Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1.
Zhang Y; Fondell JD; Wang Q; Xia X; Cheng A; Lu ML; Hamburger AW
Oncogene; 2002 Aug; 21(36):5609-18. PubMed ID: 12165860
[TBL] [Abstract][Full Text] [Related]
8. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS
Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of the androgen receptor by bombesin and low-dose androgen.
Dai J; Shen R; Sumitomo M; Stahl R; Navarro D; Gershengorn MC; Nanus DM
Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445
[TBL] [Abstract][Full Text] [Related]
12. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
13. Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells.
Shin T; Sumiyoshi H; Matsuo N; Satoh F; Nomura Y; Mimata H; Yoshioka H
Arch Biochem Biophys; 2005 Mar; 435(2):291-302. PubMed ID: 15708372
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers.
Takahashi S; Inaguma S; Sakakibara M; Cho YM; Suzuki S; Ikeda Y; Cui L; Shirai T
Prostate; 2002 Jun; 52(1):82-8. PubMed ID: 11992622
[TBL] [Abstract][Full Text] [Related]
15. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells.
Yuan HQ; Kong F; Wang XL; Young CY; Hu XY; Lou HX
Biochem Pharmacol; 2008 Jun; 75(11):2112-21. PubMed ID: 18430409
[TBL] [Abstract][Full Text] [Related]
17. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Jackson KM; Frazier MC; Harris WB
Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
19. [The roles of c-Jun and CBP in the inhibitory effect of quercetin on prostate cancer cells].
Yuan HQ; Guo HF; He ML; Kong F; Hu XY; Jiang AL; Xu X; Zhang JY; Charles YF
Yao Xue Xue Bao; 2006 Sep; 41(9):819-24. PubMed ID: 17111826
[TBL] [Abstract][Full Text] [Related]
20. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]